financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Market
financetom
/
Market
/
Quantum Biopharma up in U.S. Pre-market, Says Phase 1 Lucid-MS Trial Completed With no Safety Concerns
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Quantum Biopharma up in U.S. Pre-market, Says Phase 1 Lucid-MS Trial Completed With no Safety Concerns
Feb 26, 2025 6:04 AM

08:53 AM EST, 02/26/2025 (MT Newswires) -- Quantum BioPharma ( QNTM ) rose 6.6% in U.S. pre-market trading on Wednesday after saying its Phase 1 trial investigating the safety and pharmacokinetics of its lead candidate Lucid-MS has been completed with no serious adverse events being reported.

According to a statement, a final safety review committee meeting concluded that Lucid-MS was well-tolerated with no safety concerns. The trial involved healthy adult participants.

Lucid-MS is a non-immunomodulatory, neuroprotective compound for the treatment of multiple sclerosis (MS). It has a unique mechanism of action and has been shown to directly stabilize the myelin sheath surrounding nerve fibers in preclinical models.

The company's shares were last seen up US$0.37 to US$5.95 in U.S. pre-market trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
S&P 500 Gains For 3rd Day Amid US-China Trade Talks: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
S&P 500 Gains For 3rd Day Amid US-China Trade Talks: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
Jun 11, 2025
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Greed” zone on Tuesday. U.S. stocks settled higher on Tuesday, as the Dow Jones index gained more than 100 points during the session, with investors closely watching for potential progress in ongoing U.S.-China trade negotiations taking place in London....
 Japan's Nikkei climbs for fourth day on US-China trade truce hopes
Japan's Nikkei climbs for fourth day on US-China trade truce hopes
Jun 11, 2025
(Updates to market close) By Rocky Swift TOKYO, June 11 (Reuters) - Japan's Nikkei share gauge climbed for a fourth straight session on Wednesday after a tentative trade truce between the U.S. and China supported demand for higher-yielding assets. The Nikkei 225 Index gained 0.6% and logged its longest winning streak in about a month. Year-to-date, it is down 4.2%....
 Euro zone yields mixed before US data, markets await details on US-China deal
Euro zone yields mixed before US data, markets await details on US-China deal
Jun 10, 2025
June 11 (Reuters) - Euro zone government bond yields were mixed on Wednesday as investors awaited U.S. consumer price index data later in the session and details of the outcome of trade talks between the U.S. and China. U.S. and Chinese officials agreed on a framework to put their trade truce back on track while offering little sign of a...
 Crude Oil Prices Edge Up on U.S.-China Trade Talks
Crude Oil Prices Edge Up on U.S.-China Trade Talks
Jun 11, 2025
05:09 AM EDT, 06/11/2025 (MT Newswires) -- Crude oil prices continued to nudge higher on Wednesday on developments in trade talks between the U.S. and China, two of the world's largest oil consumers. Brent crude at last look rose 0.1% to US$66.94/barrel and West Texas Intermediate crude gained 0.3% to US$65.15/b. Officials from the U.S. and China agreed on a...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2025 - www.financetom.com All Rights Reserved